Merck is a member of numerous industry and trade groups. We work with these groups because they represent the pharmaceutical industry and business community in debates led by governments and other stakeholders, and because they are important in helping to reach industry consensus on policy issues. At times we may not share the views of our peers or associations. Merck representatives on the boards and committees of industry groups and associations ensure that we voice questions or concerns we may have about policy or related activities. We may even recuse ourselves from related association or industry group activities.
Following is a partial listing of industry and trade groups in which we are members:
|Business Council for International Understanding (BCIU) International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) World Economic Forum|
Regional & National Organizations*
|American Chamber of Commerce in Japan (ACCJ) Asia Society Association of the British Pharmaceutical Industry (ABPI) BioteCanada Canada's Research-Based Pharmaceutical Companies (Rx&D) European Federation of Pharmaceutical Industries and Associations (EFPIA) Farmaindustria (Italy) Farmaindustria (Spain) Federation of Pharmaceutical Manufacturers of Japan (FPMAJ) French Pharmaceutical Companies Association German Association of Research-Based Pharmaceutical Companies Japan Business Federation (Nippon Keidanren) Japan Pharmaceutical Manufacturers Association (JPMA) Mexican Association of Pharmaceutical Research (AMIIF) TransAtlantic Business Dialogue (TABD) U.S.-ASEAN Business Council U.S.-China Business Council U.S.-India Business Council U.S.-Japan Business Council|
|Alliance for Health Reform Biotechnology Industry Organization (BIO) Business Roundtable Conference Board Council on Competitiveness Healthcare Leadership Council National Association of Manufacturers National Health Council National Pharmaceutical Council Pharmaceutical Research and Manufacturers of America (PhRMA) U.S. Chamber of Commerce|
*We also are members of national pharmaceutical industry associations in many other countries in which we operate.
**Merck is also a member of chambers of commerce and pharmaceutical - and biotechnology-related trade associations in numerous states.
|Animal Health Institute****||$10,391||$7,638||$10, 608||---|
|Bio New Jersey**||$1,175||$1,175||$1,625||---|
|Biotechnology Industry Organization||$285,300||$293,075||$278,800||$144,500|
|California Healthcare Institute||$10,200||$15,000||$15,000||$15,000|
|Consumer Healthcare Products Association****||$80,923||$91,135||$34,139||---|
|Council of the Americas**||$1,250||$1,250||$1,250||---|
|Healthcare Institute of New Jersey||$130,795||$140,820||$123,440||$81,540|
|Healthcare Leadership Council||$120,000||$120,000||$120,000||$120,000|
|National Association of Manufacturers***||$51,670||$47,379||$63,171||---|
|New Jersey Lawsuit Reform Alliance||$3,000||$7,500||---||---|
|Pennsylvania Biotechnology Association**||$2,000||$2,000||$2,000||---|
|Personal Care Products Council****||$44,148||$31,295||$28,299||---|
|Pharmaceutical Research and Manufacturers of America||$6,517,099||$6,235,099||$7,046,747||$12,767,272|
|Texas Healthcare & Bioscience Institute**||$3,500||$3,500||$3500||---|
|U.S. Chamber of Commerce||$907,500||$725,000||$725,000||$320,000|
*Includes associations where dues are > $25,000. Because the U.S. tax law that requires this reporting does not apply outside the United States, trade associations that are not subject to this do not provide breakouts of lobbying expenditures from membership dues.
**Prior to 2011, Merck reported the portion of dues used for advocacy and/or political activities by those associations where our dues were >$50,000. In 2011, we lowered our reporting threshold to >$25,000 in response to stakeholder input.
***Merck inadvertently did not report dues for NAM in previous years.
****In 2011, we began reporting trade association dues used for advocacy and/or political activities for our animal and consumer health businesses.
Merck and Schering-Plough are now one company. We are working to update our public policy position statements to reflect our new global organization. In the meantime, please click on the links below to learn more about our views and positions.